It used to be that, at age 65, people would retire and get Medicare. Not any longer. According to the Bureau of Labor Statistics, almost 9 million Americans 65 or older reported being employed full- or part-time. And still working at Medicare age comes with costly and complicated traps.
In this recording of a live webinar featuring nationally-recognized Medicare expert, Diane J. Omdahl, RN, MS, you’ll learn how you can help your clients avoid three of the most costly Medicare mistakes.
But, that does not mean that you have to have all those Medicare regulations memorized...
If you're like most financial professionals today, you most likely get questions from your clients (or prospective clients) about Medicare.
Unfortunately, these professionals tell us that they best they can do to help their clients is to refer them to Medicare.gov, a local Social Security office or an insurance agent. ...Not exactly an ideal way to handle questions from valued clients.
It’s a Baby Boomer’s worst nightmare: the deluge of information, both digital and analog, masks a single piece of Medicare-related mail that is responsible for costing you thousands upon thousands of dollars in unwanted costs. Forms sent by sanctioned Medicare Advantage plan providers—or if you’re lucky, a few separately-mailed items—throw a massive monkey wrench in your financial plans.
You probably aren’t surprised at this point, but signing up for Medicare can be very, very complicated. That’s why we’ve put together a short list of important things to be on the lookout for during this year’s open enrollment season. It’s no substitute for reading our other entries on the subject or contacting an expert for assistance, but if you remember these recommendations, it will go a long way toward making sure you don’t end up with thousands of dollars in unnecessary fees and bills!
It’s all well and good to secure your Medicare plan, but one of the many, many things you and your financial planner need to be aware of is the growing list of Medicare plan providers who are under sanctions from the Centers for Medicare and Medicaid Services.
Several high profile cases in the last year have demonstrated how the cost for life-saving drugs or treatment can increase dramatically without warning. The narratives of Epipen and the anti-parasitic drug Daraprim tell the heart-rending tale of patients abruptly unable to afford a drug that they desperately needed.